Recent Posts
- Illinois Attorney General Files Lawsuit Against HIV/AIDS Nonprofit
- California Gov. Arnold Schwarzenegger Signs Budget That Cuts $52M From HIV/AIDS Programs
- Efforts Underway In Namibia To Treat Pediatric HIV
- HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
- Also In Global Health News: Uganda Male Circumcision; Malaria Vaccine; Potential Global Fund Grant In Cambodia; PMTCT Of HIV In Botswana
Random Posts
- More Camden, N.J., Residents Using Needle Exchange Programs
- Terrence Higgins Trust Gets Shropshire, Telford & Wrekin Involved In World AIDS Day
- Medicare To Pay For HIV Testing
- Grenadian Prime Minister Calls For Continued Investment In Caribbean HIV/AIDS Programs
- The Gambia's Army Holds Program To Encourage HIV/AIDS Awareness, Leadership
- Miller School Researchers Publish Findings On Kaposi's Sarcoma
- Also In Global Health News: HIV Aid For Vietnam; Gates To Meet With WHO; Women's Health In Philippines; Zambian Health Workers; HIV In Ghana
- National AIDS Fund Lauds Initiative To Remove Ban On Federal Funding For Syringe Exchange Programs
- Two Physicians Treat Most Residents With HIV In Southeastern Wyoming
- National Survey Looks At HIV/AIDS In South Africa
Prescription AIDS Drugs
Contact Us
TB-Prevention Therapy Found To Be A Cost-Effective Option
July 22nd, 2010
University of Alabama at Birmingham (UAB) researchers have found that the cost of preventive antibiotic tuberculosis (TB) therapy for patients infected by human immunodeficiency virus (HIV) is generally less expensive than the reported cost of treating newly confirmed TB cases.
The study, published in The International Journal of Tuberculosis and Lung Disease this summer, relied on treatment-cost estimates from previous research studies and data collected by members of the study’s research team at a TB treatment site in Cambodia.
“We completed this study to provide health-program managers cost and cost-effectiveness data on components of a comprehensive package of HIV care. This data is essential to help establish feasible and effective ways to manage patients with human immunodeficiency virus infection and tuberculosis in a developing country,” said Bryce Sutton, Ph.D., an economist in the UAB School of Business and one of the study’s co-investigators.
The research found that the cost of preventing a single case of TB with intensive screening and preventive treatment with antibiotics in HIV-infected patients prior to their exposure to the disease was approximately $950. Compare that to a cost range of $900-$1500, which is the previously reported range for treating a new smear-positive TB case in a developing country setting after adjusting for inflation.
“Our analysis showed that the costs associated with screening and preventive treatment for TB among HIV-infected patients was comparable to the cost related to treating a patient with a newly confirmed case of TB,” Sutton said. “When you factor in observed high adherence rate to treatment and other cost savings such as averted productivity losses that come with stopping TB’s spread through the preventive care, we believe that this type of integrated care offers a potential savings to governments and health-care agencies.”
Sutton said preventing the spread of TB goes beyond cost-savings and can positively affect local, regional and national developing economies.
“Diseases like tuberculosis in a developing country setting can be catastrophic both in terms of health and the financial burden it places on families,” he said. “Often other family members stop working to become caretakers; children and young adults may be forced to enter the workforce to pay for expenses and forgo receiving an education, which can start a cycle of poverty.
“These are important economic factors that support the adoption of preventive-care TB policies.”
Former UAB Professor of Infectious Diseases Michael Kimerling, M.D., is the study’s co-investigator. Former UAB graduate researchers Phalkun Chheng and Mayra Arias and M.T. Eang from the National Tuberculosis and Leprosy Control (CENAT) Phnom Penh, Cambodia, also are on the research team.
Data used in the study were collected at one of four pilot treatment sites facilitated in Cambodia through the UAB-led Gorgas Tuberculosis Initiative, which was created to establish feasible and effective ways to manage patients with HIV and TB.
Source:
Andrew Hayenga
University of Alabama at Birmingham
Related posts:
- Male Circumcision Programmes As Part Of Combination HIV Prevention In Sub-Saharan Africa Are Cost Effective, Says UNAIDS Male circumcision among heterosexual men in low male circumcision, high...
- Directly Observed Antiretroviral Therapy Offers No Benefit Over Self-Administered Treatment For HIV Patients Directly observed antiretroviral therapy-in which a health worker or other...
- Early Initiation Of Antiretroviral Therapy Improves HIV Survival Rates, Study Says The New York Times on Thursday examined a study that...
- New Jersey Should Continue Efforts To Provide No-Cost HIV Testing, Editorial Says No-cost HIV testing “should continue to be available and easily...
- First Engineered T Cell Receptor Trial Opens With New Cellular Therapy For HIV Researchers at the University of Pennsylvania School of Medicine and...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.